TRIS PHARMA
LIVE

Serial Number

88824840

Owner

TRIS PHARMA, INC

Attorney

Cathy A. Kodroff

First Use Date

Jan 1, 2015

Filing Date

Mar 6, 2020

Add to watchlist:

No watchlists yet
View on USPTO

TRIS PHARMA Trademark

Serial Number: 88824840 • Registration: 6298220

TRIS PHARMA is a trademark filed by TRIS PHARMA, INC on March 6, 2020. The trademark is classified under Class 5 (Pharmaceuticals), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

TRIS PHARMA, INC

2031 US Highway 130
Monmouth Junction, NJ 08852

Entity Type: 03

Trademark Details

Filing Date

March 6, 2020

Registration Date

March 23, 2021

First Use Anywhere

January 1, 2015

First Use in Commerce

January 1, 2015

Published for Opposition

January 5, 2021

Goods & Services

Providing information relating to therapeutic properties of pharmaceutical preparations; providing a website featuring information relating to therapeutic properties of pharmaceutical preparations

Pharmaceutical preparations, namely, beta-Hydroxy beta-methylglutaryl-CoA (HMG-CoA) reductase inhibitors used to lower LDL cholesterol and to treat hypertriglyceridemia as an adjunct to diet, cholesterol lowering medications; pharmaceutical preparations that act as central nervous system stimulants; pharmaceutical preparations, namely, neuromodulators for treatment of psychiatric disorders and disorders related to attention-deficit hyperactivity disorder; pharmaceutical preparations for the treatment of attention-deficit hyperactivity disorder (ADHD); liquid oral pharmaceutical preparations for the treatment of attention-deficit hyperactivity disorder (ADHD); solid pharmaceutical preparations for the treatment of attention-deficit hyperactivity disorder (ADHD); pharmaceutical preparations for the treatment of narcolepsy; pharmaceutical preparations for the treatment of chronic lung disease; pharmaceutical preparations for the treatment of colds; pharmaceutical preparations for the treatment of coughs; extended release liquid for the treatment of coughs; pharmaceutical preparations for the treatment of upper respiratory symptoms; pharmaceutical preparations for the treatment of pain

Filing History

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Mar 23, 2026 REM1
REGISTERED-PRINCIPAL REGISTER
Mar 23, 2021 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 5, 2021 NPUB
PUBLISHED FOR OPPOSITION
Jan 5, 2021 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 16, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 1, 2020 CNSA
EXAMINER'S AMENDMENT ENTERED
Dec 1, 2020 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Dec 1, 2020 GNEN
EXAMINERS AMENDMENT E-MAILED
Dec 1, 2020 GNEA
EXAMINERS AMENDMENT -WRITTEN
Dec 1, 2020 CNEA
EXAMINER'S AMENDMENT ENTERED
Dec 1, 2020 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Dec 1, 2020 GNEN
EXAMINERS AMENDMENT E-MAILED
Dec 1, 2020 GNEA
EXAMINERS AMENDMENT -WRITTEN
Dec 1, 2020 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 25, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 24, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 24, 2020 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 3, 2020 GNRN
NON-FINAL ACTION E-MAILED
Jun 3, 2020 GNRT
NON-FINAL ACTION WRITTEN
Jun 3, 2020 CNRT
ASSIGNED TO EXAMINER
May 27, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 12, 2020 NWOS
NEW APPLICATION ENTERED
Mar 10, 2020 NWAP